Microfluidics Market (By Material: Glass, Silicon, PDMS, Polymers, and Others; By Technology: Non-Medical and Medical; By Application: Organs-on-chips, Lab-on-a-chip, Continuous Flow Microfluidics, Acoustofluidics and Microfluidics, Optofluidics and Microfluidics, and Electrophoresis and Microfluidics) - Global Market Size, Trends Analysis, Segment Forecasts, Regional Outlook 2024-2034
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Microfluidics Market, by Material Type, 2024-2034
7.1.1. Glass
7.1.1.1. Market Revenue and Forecast (2021-2034)
7.1.2. Silicon
7.1.2.1. Market Revenue and Forecast (2021-2034)
7.1.3. PDMS
7.1.3.1. Market Revenue and Forecast (2021-2034)
7.1.4. Polymers
7.1.4.1. Market Revenue and Forecast (2021-2034)
7.1.5. Others
7.1.5.1. Market Revenue and Forecast (2021-2034)
8.1. Microfluidics Market, by Application, 2024-2034
8.1.1. Organs-on-chips
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Lab-on-a-chip
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Continuous Flow Microfluidics
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Acoustofluidics and Microfluidics
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Optofluidics and Microfluidics
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Electrophoresis and Microfluidics
8.1.6.1. Market Revenue and Forecast (2021-2034)
9.1. Microfluidics Market, by Technology, 2024-2034
9.1.1. Non-Medical
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Medical (Gel Electrophoresis, PCR & RT-PCR, ELISA, Microarrays, Others)
9.1.2.1. Market Revenue and Forecast (2021-2034)
10.1. North America
10.1.1. Market Revenue and Forecast, by Material (2021-2034)
10.1.2. Market Revenue and Forecast, by Application (2021-2034)
10.1.3. Market Revenue and Forecast, by Technology (2021-2034)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Material (2021-2034)
10.1.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.1.4.3. Market Revenue and Forecast, by Technology (2021-2034)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Material (2021-2034)
10.1.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.1.5.3. Market Revenue and Forecast, by Technology (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Material (2021-2034)
10.2.2. Market Revenue and Forecast, by Application (2021-2034)
10.2.3. Market Revenue and Forecast, by Technology (2021-2034)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Material (2021-2034)
10.2.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.2.4.3. Market Revenue and Forecast, by Technology (2021-2034)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Material (2021-2034)
10.2.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.2.5.3. Market Revenue and Forecast, by Technology (2021-2034)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Material (2021-2034)
10.2.6.2. Market Revenue and Forecast, by Application (2021-2034)
10.2.6.3. Market Revenue and Forecast, by Technology (2021-2034)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Material (2021-2034)
10.2.7.2. Market Revenue and Forecast, by Application (2021-2034)
10.2.7.3. Market Revenue and Forecast, by Technology (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Material (2021-2034)
10.3.2. Market Revenue and Forecast, by Application (2021-2034)
10.3.3. Market Revenue and Forecast, by Technology (2021-2034)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Material (2021-2034)
10.3.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.3.4.3. Market Revenue and Forecast, by Technology (2021-2034)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Material (2021-2034)
10.3.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.3.5.3. Market Revenue and Forecast, by Technology (2021-2034)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Material (2021-2034)
10.3.6.2. Market Revenue and Forecast, by Application (2021-2034)
10.3.6.3. Market Revenue and Forecast, by Technology (2021-2034)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Material (2021-2034)
10.3.7.2. Market Revenue and Forecast, by Application (2021-2034)
10.3.7.3. Market Revenue and Forecast, by Technology (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Material (2021-2034)
10.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.4.3. Market Revenue and Forecast, by Technology (2021-2034)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Material (2021-2034)
10.4.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.4.4.3. Market Revenue and Forecast, by Technology (2021-2034)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Material (2021-2034)
10.4.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.4.5.3. Market Revenue and Forecast, by Technology (2021-2034)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Material (2021-2034)
10.4.6.2. Market Revenue and Forecast, by Application (2021-2034)
10.4.6.3. Market Revenue and Forecast, by Technology (2021-2034)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Material (2021-2034)
10.4.7.2. Market Revenue and Forecast, by Application (2021-2034)
10.4.7.3. Market Revenue and Forecast, by Technology (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Material (2021-2034)
10.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.5.3. Market Revenue and Forecast, by Technology (2021-2034)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Material (2021-2034)
10.5.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.5.4.3. Market Revenue and Forecast, by Technology (2021-2034)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Material (2021-2034)
10.5.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.5.5.3. Market Revenue and Forecast, by Technology (2021-2034)
11.1. Agilent Technologies, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Illumina, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Perkinelmer, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Life Technologies Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Danaher
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Bio-Rad Laboratories, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Hoffmann-La Roche Ltd
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Abbott Laboratories
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Fluidigm Corporation
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Qiagen N.V.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Thermo Fischer Scientific
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Biomérieux
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Cellix Ltd.
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. Elveflow
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. Micronit Micro Technologies B.V.
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client